Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma

Authors: Dagher, Christian ^a, Bjerre Trent, Pernille ^{b, c}, Alwaqfi, Rofieda ^d, Davidson, Ben ^{c, e}, Ellenson, Lora H. ^d, Zhou, Qin ^f, Iasonos, Alexia ^f, Mueller, Jennifer J. ^{a, g}, Alektiar, Kaled ^h, Makker, Vicky ^{i, j}, Feinberg, Jacqueline ^{a, g}, Smith, Evan ^{a, g}, Kim, Sarah H. ^{a, g}, Hatoum, Sana ^a, Leitao, Mario M., Jr. ^{a, g}, Abu-Rustum, Nadeem R. ^{a, g, ⁎}, Eriksson, Ane Gerda Z. ^{b, c}

Source: In International Journal of Gynecological Cancer January 2025

Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary

Authors: Finch, Lindsey ^{a, 1}, Andres, Sarah ^{a, 1}, Iasonos, Alexia ^b, Zhou, Qin ^b, Girshman, Jeffrey ^c, Chhetri-Long, Rashmi ^d, Green, Hunter ^e, Selenica, Pier ^e, Jang, Dasom ^d, O’Cearbhaill, Roisin E. ^{d, f}, Kyi, Chrisann ^{d, f}, Cohen, Seth ^{d, f}, Friedman, Claire F. ^{d, f}, Makker, Vicky ^{d, f}, Chi, Dennis S. ^{a, g}, Sonoda, Yukio ^{a, g}, Chiang, Sarah ^e, Aghajanian, Carol ^{d, f}, Weigelt, Britta ^e, Grisham, Rachel N. ^{d, f, ⁎}

Source: In International Journal of Gynecological Cancer January 2025 35(1)

Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometrium

Authors: Rios-Doria, Eric, Nobre, Silvana Pedra, Sassine, Dib, Glaser, Gretchen, Eriksson, Ane Gerda, Ataseven, Beyhan, du Bois, Andreas, Makker, Vicky, Alektiar, Kaled, Leitao, Mario M., Jr, Abu-Rustum, Nadeem R., Mueller, Jennifer J.

Source: In Gynecologic Oncology November 2024 190:236-242

Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort study

Authors: Dagher, Christian ¹, Bjerre Trent, Pernille ^{2, 3}, Alwaqfi, Rofieda ⁴, Davidson, Ben ^{3, 5}, Ellenson, Lora ⁴, Zhou, Qin C ⁶, Iasonos, Alexia ⁶, Mueller, Jennifer J ^{1, 7}, Alektiar, Kaled ⁸, Makker, Vicky ^{9, 10}, Kim, Sarah ^{1, 7}, Leitao, Mario M, Jr ^{1, 7}, Abu-Rustum, Nadeem R ^{1, 7, *}, Eriksson, Ane Gerda Z ^{2, 3}

Source: In International Journal of Gynecological Cancer October 2024 34(10):1485-1492

Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer

Authors: Andres, Sarah, Finch, Lindsey, Iasonos, Alexia, Zhou, Qin, Girshman, Jeffrey, Chhetri-Long, Rashmi, Green, Hunter, Jang, Dasom, O'Cearbhaill, Roisin, Kyi, Chrisann, Cohen, Seth, Friedman, Claire, Makker, Vicky, Chi, Dennis S., Sonoda, Yukio, Chiang, Sarah, Aghajanian, Carol, Weigelt, Britta, Grisham, Rachel N.

Source: In Gynecologic Oncology October 2024 189:30-36

Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer

Authors: Rios-Doria, Eric ¹, Abu-Rustum, Nadeem R ^{1, 2}, Alektiar, Kaled M ³, Makker, Vicky ^{4, 5}, Liu, Ying L ^{4, 5}, Zamarin, Dmitriy ^{4, 5}, Friedman, Claire F ^{4, 5}, Aghajanian, Carol ^{4, 5}, Ellenson, Lora H ⁶, Chiang, Sarah ⁶, Weigelt, Britta ⁶, Mueller, Jennifer J ^{1, 2}, Leitao, Mario M ^{1, 2, *}

Source: In International Journal of Gynecological Cancer September 2024 34(9):1373-1381

Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study

Authors: Makker, Vicky, Perez-Fidalgo, Jose Alejandro, Valabrega, Giorgio, Hamilton, Erika, Van Gorp, Toon, Sehouli, Jalid, Regináčová, Klaudia, Richardson, Debra L., Perri, Tamar, Oza, Amit M., Miller, David S., Alía, Eva Maria Guerra, De Giorgi, Ugo, Henry, Stephanie, Spitz, Daniel L., Wimberger, Pauline, Bednaříková, Markéta, Chon, Hye Sook, Martínez-Garcia, Jerónimo, Pisano, Carmela, Berek, Jonathan S., Romero, Ignacio, Scambia, Giovanni, Fariñas-Madrid, Lorena, Buscema, Joseph, Schochter, Fabienne, Li, Kai, Kalyanapu, Pratheek, Walker, Christopher J., Vergote, Ignace

Source: In Gynecologic Oncology June 2024 185:202-211

Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series

Authors: Sia, Tiffany Y ¹, Wan, Vivian ², Finlan, Michael ¹, Zhou, Qin C ³, Iasonos, Alexia ³, Zivanovic, Oliver ^{1, 4}, Sonoda, Yukio ^{1, 4}, Chi, Dennis S ^{1, 4}, Long Roche, Kara ^{1, 4}, Jewell, Elizabeth ^{1, 4}, Tew, William P ^{5, 6}, O'Cearbhaill, Roisin E ^{5, 6}, Cohen, Seth ^{5, 6}, Makker, Vicky ^{5, 6}, Liu, Ying L ^{5, 6}, Friedman, Claire F ^{5, 6}, Kyi, Chrisann ^{5, 6}, Zamarin, Dmitriy ^{5, 6}, Gardner, Ginger ^{1, 4, *}

Source: In International Journal of Gynecological Cancer April 2024 34(4):594-601

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Authors: Lumish, Melissa, Chui, M. Herman, Zhou, Qin, Iasonos, Alexia, Sarasohn, Debra, Cohen, Seth, Friedman, Claire, Grisham, Rachel, Konner, Jason, Kyi, Chrisann, Rubinstein, Maria, Troso-Sandoval, Tiffany, Aghajanian, Carol, Makker, Vicky

Source: In Gynecologic Oncology March 2024 182:75-81

Laparoscopy with or without robotic assistance does not negatively impact long-term oncologic outcomes in patients with uterine serous carcinoma

Authors: Sia, Tiffany Y., Basaran, Derman, Dagher, Christian, Sassine, Dib, Brandt, Benny, Rosalik, Kendall, Mueller, Jennifer J., Broach, Vance, Makker, Vicky, Soslow, Robert A., Abu-Rustum, Nadeem R., Leitao, Mario M.

Source: Gynecologic oncology. 175:8-14

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100195187663.0x000001&indx=1&recIds=ETOCvdc_100195187663.0x000001

Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

Authors: Rios-Doria, Eric, Momeni-Boroujeni, Amir, Friedman, Claire F., Selenica, Pier, Zhou, Qin, Wu, Michelle, Marra, Antonio, Leitao, Mario M., Iasonos, Alexia, Alektiar, Kaled M., Sonoda, Yukio, Makker, Vicky, Jewell, Elizabeth, Liu, Ying, Chi, Dennis, Zamarin, Dimitry, Abu-Rustum, Nadeem R., Aghajanian, Carol, Mueller, Jennifer J., Ellenson, Lora H., Weigelt, Britta

Source: Gynecologic oncology. 174:262-272

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194216620.0x000001&indx=1&recIds=ETOCvdc_100194216620.0x000001

Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations

Authors: Rimel, Bobbie J., Crane, Erin K., Hou, June, Nakayama, John, MacDonald, Jennifer, Lutz, Kathleen, Makker, Vicky, O'Cearbhaill, Roisin E.

Source: Gynecologic oncology. 174:148-156

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194216772.0x000001&indx=1&recIds=ETOCvdc_100194216772.0x000001

Germline drivers of gynecologic carcinosarcomas

Authors: Sia, Tiffany Y., Gordhandas, Sushmita B., Birsoy, Ozge, Kemel, Yelena, Maio, Anna, Salo-Mullen, Erin, Sheehan, Margaret, Hensley, Martee L., Rubinstein, Maria, Makker, Vicky, Grisham, Rachel N., O'Cearbhaill, Roisin E., Roche, Kara Long, Mueller, Jennifer J., Leitao, Mario M., Sonoda, Yukio, Chi, Dennis S., Abu-Rustum, Nadeem R., Berger, Michael F., Ellenson, Lora H., Latham, Alicia, Stadler, Zsofia, Offit, Kenneth, Aghajanian, Carol, Weigelt, Britta, Mandelker, Diana, Liu, Ying L.

Source: Gynecologic oncology. 174:34-41

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194216969.0x000001&indx=1&recIds=ETOCvdc_100194216969.0x000001

Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice

Authors: Lorusso, Domenica, Colombo, Nicoletta, Herraez, Antonio Casado, Santin, Alessandro D., Colomba, Emeline, Miller, David Scott, Fujiwara, Keiichi, Pignata, Sandro, Baron-Hay, Sally E., Ray-Coquard, Isabelle Laure, Shapira-Frommer, Ronnie, Kim, Yong Man, McCormack, Mary, Massaad, Rachid, Nguyen, Allison Martin, Zhao, Qi, McKenzie, Jodi, Prabhu, Vimalanand S., Makker, Vicky

Source: European journal of cancer. 186:172-184

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194198298.0x000001&indx=1&recIds=ETOCvdc_100194198298.0x000001

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Authors: Rubinstein, Maria M., Doria, Eric Rios, Konner, Jason, Lichtman, Stuart, Zhou, Qin, Iasonos, Alexia, Sarasohn, Debra, Troso-Sandoval, Tiffany, Friedman, Claire, O'Cearbhaill, Roisin, Cadoo, Karen, Kyi, Chrisann, Cohen, Seth, Soldan, Krysten, Billinson, Eric, Caird, Imogen, Jang, Dasom, Eid, Khalil, Shah, Pooja, Guillen, Joyce, Aghajanian, Carol, Zamarin, Dmitriy, Makker, Vicky

Source: Gynecologic oncology. 169:64-69

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190035271.0x000001&indx=1&recIds=ETOCvdc_100190035271.0x000001

A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update

Authors: Makker, Vicky, Aghajanian, Carol, Cohn, Allen L., Romeo, Margarita, Bratos, Raquel, Brose, Marcia S., Messing, Mark, Dutta, Lea, Dutcus, Corina E., Huang, Jie, Schmidt, Emmett V., Orlowski, Robert, Taylor, Matthew H.

Source: Journal of clinical oncology. 41(5):974-979

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100181430428.0x000001&indx=1&recIds=ETOCvdc_100181430428.0x000001

Isolated vaginal recurrence in women with stage I endometrial cancer

Authors: Rios-Doria, Eric, Cun, Han T., Filippova, Olga T., Mueller, Jennifer J., Alektiar, Kaled M., Ellenson, Lora H., Makker, Vicky, Lakhman, Yulia, Leitao, Mario M., Jr, Jhingran, Anuja, Soliman, Pamela T., Abu-Rustum, Nadeem R.

Source: In Gynecologic Oncology December 2023 179:9-15

HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer

Authors: Shen, Sherry, Ma, Weining, Brown, David, Da Cruz Paula, Arnaud, Zhou, Qin, Iaosonos, Alexia, Tessier-Cloutier, Basile, Ross, Dara S., Troso-Sandoval, Tiffany, Reis-Filho, Jorge S., Abu-Rustum, Nadeem, Zhang, Yanming, Ellenson, Lora H., Weigelt, Britta, Makker, Vicky, Chui, M. Herman

Source: In Modern Pathology November 2023 36(11)

A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer

Authors: Han, Sileny N., Oza, Amit, Colombo, Nicoletta, Oaknin, Ana, Raspagliesi, Francesco, Wenham, Robert M., Braicu, Elena Ioana, Jewell, Andrea, Makker, Vicky, Krell, Jonathan, Alía, Eva María Guerra, Baurain, Jean-François, Su, Zhenqiang, Neuwirth, Rachel, Vincent, Sylvie, Sedarati, Farhad, Faller, Douglas V., Scambia, Giovanni

Source: In Gynecologic Oncology November 2023 178:110-118

Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer

Authors: Zammarrelli, William A., III, Ma, Weining, Espino, Kevin, Gordhandas, Sushmita, Yeoshoua, Effi, Ehmann, Sarah, Zhou, Qin, Iasonos, Alexia, Abu-Rustum, Nadeem R., Aghajanian, Carol, Green, Angela K., Rubinstein, Maria M., Makker, Vicky

Source: In Gynecologic Oncology November 2023 178:27-35